The largest database of trusted experimental protocols

Hybond p pvdf

Manufactured by GE Healthcare
Sourced in United Kingdom

Hybond-P PVDF is a polyvinylidene fluoride (PVDF) membrane used for protein transfer and detection in Western blotting applications. The membrane provides high protein binding capacity and durability, allowing for effective capture and immobilization of proteins during the blotting process.

Automatically generated - may contain errors

8 protocols using hybond p pvdf

1

Radiation-Induced Protein Expression Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated in serum-free medium for 4 h followed by irradiation (1.8 Gy). After 24h, cells were lysed and 50 µg of proteins from each sample were run on a 6–12% SDS-PAGE gel and transferred to a PVDF Hybond-P (GE Healthcare, Brazil) membrane. Membranes were incubated with antibodies against EGFR (1:500; #2232, Cell Signaling Technology, USA), ERCC1 (1:100; 8F1 clone, Thermo Fisher Scientific, USA), p53 (1:500; G59–12 clone, BD Pharmingen, USA) and HSC70 (heat shock cognate 70 protein; 1:5000; Santa Cruz Biotechnology, USA). After incubation with secondary antibodies, immunoblots were detected using the ECL reagent (GE Healthcare, Brazil). Predicted molecular weights for EGFR, ERCC1, p53, and HSC70 are 170, 39, 53, and 70 kDa, respectively.
+ Open protocol
+ Expand
2

Western Blot Analysis of Intoxicated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intoxicated cells (T84 cells or HUVECs) were washed with cold PBS and scraped with lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP40, 2 mM Na3VO4, 1 mM EDTA, 1 μM aprotinin, 25 μM leupeptin, 1 μM pepstatin, 1 mM AEBSF, 10 mM NaF, 5 mM NaPPi, 10 mM β-glycerophosphate). The lysate was sonicated and solubilized for 30 min at 4 °C and then centrifuged at 14,000 rpm for 20 min at 4 °C. The protein concentration of the supernatant was determined using Bio-Rad DC reagents (Bio-Rad, Marnes-la-Coquette, France). Equal amounts (50 μg) of whole cell lysates were subjected to a 12% SDS-polyacrylamide gel. The proteins were transferred onto a polyvinylidene fluoride membrane (PVDF Hybond-P, Amersham, GE Healthcare, Velizy-Villacoublay, France) and incubated overnight at 4 °C with anti-MEK-2-N20 (Santa Cruz Biotechnology, Inc., Heidelberg, Germany) or anti-PA (GeneTex Inc., Irvine, CA, USA) primary antibodies followed by HRP-conjugated anti-rabbit or anti-mouse secondary antibodies, respectively (New England Biolabs, Evry, France). The blots were developed using the Enhanced Chemiluminescence detection system (GE Healthcare Life Sciences, Little Chalfont, UK).
+ Open protocol
+ Expand
3

Western Blot Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts and culture supernatants were separated on SDS/PAA gels, transferred onto Hybond-P PVDF (GE Healthcare) membranes, and incubated overnight with primary antibodies (SI Appendix, Table S1) at 4 °C as described previously (28 (link)). Subsequently, filters were washed and incubated for 1 h with HRP-conjugated secondary antibodies (SI Appendix, Table S1). Signals were developed using WesternBright Chemilumineszenz Substrat Quantum (Biozym) and visualized with a ChemiDoc Imaging System (Bio-Rad). Quantification was performed by using ImageJ software.
+ Open protocol
+ Expand
4

Western blot analysis protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RIPA buffer (Thermo Fisher Scientific, Inc., Rockford, IL, USA) was used for preparation of whole cell extracts and the protein concentration was measured by the Bradford method (Bio-Rad Laboratories, Hercules, CA, USA). Equal amounts of cell lysates were separated on SDS-PAGE and then transferred onto Hybond-P PVDF (GE Healthcare, Buckinghamshire, UK) using a CAPS transfer buffer at 30 mA overnight at 4 °C. The membranes were blocked in a freshly made blocking buffer (5% skim milk in PBS with 0.05% Tween 20, pH 7.4, PBS-T) for 6 h at room temperature. After washing with PBS-T, the membranes were incubated with an appropriate dilution (1:1000‒1:5000) of primary antibody (Table 1) overnight at 4 °C on a rocking platform. The membranes were then washed and incubated with suitable horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA, at a dilution of 1:10,000‒1:25,000) for 1 h at room temperature. The blots of were incubated by ECL Prime (GE Healthcare), and the chemiluminescent signals were then visualized with X-ray film. Densitometry of the bands was analyzed by ImageJ software version 1.50 (National Institutes of Health, Bethesda, MD, USA).
+ Open protocol
+ Expand
5

Quantitative Immunoblotting Analysis of Protein Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymatic protein levels were evaluated as previously reported [47 (link)] by resolving 35 µg of each protein sample by SDS-PAGE (12%). The gels were electroblotted onto hydrophobic polyvinylidene difluoride membranes (Hybond-P PVDF, GE Healthcare Bio-Science, Uppsala, Sweden). Antibody staining was performed with a chemiluminescence detection system (ECL Plus Western Blotting Detection Reagent, GE Healthcare Bio-Science, Uppsala, Sweden) using a 1:500 dilution of the mouse anti-human TS (TS106) monoclonal primary antibody (Invitrogen S.r.L., Milan, Italy), 1:1000 dilutions of the mouse anti-human DHFR monoclonal antibody (Tebu-Bio, Milan, Italy), and 1:1000 of mouse anti-human ß-actin antibody (Sigma-Aldrich S.r.L., Milan, Italy) in conjunction with a 1:3000 dilution of horseradish peroxidase-conjugated sheep anti-mouse secondary antibody (GE Healthcare Bio-Science, Uppsala, Sweden). Quantification of signal intensity was performed by densitometry on a GS-800 calibrated densitometer (Bio-Rad) and analysed by using Quantity One software (Bio-Rad, Hercules, CA, USA).
+ Open protocol
+ Expand
6

Protein Blotting and Detection Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hybond-P PVDF and ECL nitrocellulose membranes
were purchased from GE Healthcare (Chicago, IL). The 75 g/m2 uncoated print paper (printing paper) was purchased from Hankuk
Paper (Seoul, Republic of Korea). The antimouse IgG-HRP antibody was
purchased from Cell Signaling Technology (Danvers, MA). The recombinant
human PSMA protein was purchased from Abcam (Cambridge, UK). Recombinant
human TNF-α protein was obtained from Sigma-Aldrich (St. Louis,
MO). Anti-PSMA antibody-HRP was obtained from Lifespan Biosciences
(Washington, WA). Anti-TNF-α antibody-HRP was purchased from
Abcam. The ECL western blot detection system was purchased from GE
Healthcare. The piezo printhead printer (XP-310) was obtained from
Epson (Suwa, Japan).
+ Open protocol
+ Expand
7

Western Blot Analysis of LPS-Stimulated RAW 264.7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confluent RAW 264.7 cells (1 × 106/mL) were incubated with vehicle, LPS plus vehicle, or LPS plus test sample (0.05 and 0.1 mg/mL). After being incubated for 16 h, cell lysate was prepared using RIPA buffer (Thermo Fisher Scientific, Inc., Rockford, IL, USA) and the protein concentration was determined by the Bradford method (Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin as a standard.
Equal amounts of cell lysates were separated on SDS-PAGE (8%–12%) and then transferred onto Hybond-P PVDF (GE Healthcare, Buckinghamshire, UK) using a CAPS transfer buffer at 20 volt overnight at 4 °C. The membranes were blocked at room temperature in a freshly made blocking buffer (5% skim milk in PBS with 0.05% Tween 20, pH 7.4) for 6 h. The membranes were then incubated overnight at 4 °C in blocking buffer containing appropriate dilution (1:1000–1:5000) of primary antibody (Table 3). The membranes were then incubated for 1 h at room temperature with suitable horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA) at a dilution of 1:10,000–1:25,000. The proteins of interest were detected by ECL Prime (GE Healthcare) and the chemiluminescent signals were then visualized with X-ray film. Densitometry of the bands was analyzed by ImageJ software (National Institutes of Health, Bethesda, MD, USA).
+ Open protocol
+ Expand
8

Western Blot Analysis of PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells (1×106/ml) were seeded on 100 mm dishes in serum-free medium and exposed to the indicated reagent for the indicated period. Cells were washed with PBS, scraped with ice cold RIPA buffer (Thermo Fisher Scientific, Inc., Rockford, IL) and then incubated on ice for 30 min. The cellular debris was removed by centrifugation (8,000×g for 15 min) at 4°C and the cell lysate was carefully transferred to the microcentrifuge tube. The protein concentration was measured by the Bradford method (Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin as a standard.
Cell lysates were separated on 10% SDS-PAGE and transferred onto Hybond-P PVDF (GE Healthcare) at 20 volts overnight at 4°C. The membranes were blocked at 4°C in PBST blocking buffer (5% BSA in PBS with 0.05% Tween 20, pH 7.4) for 8 h. Blots were analyzed with each antibody (Table 2) at a dilution of 1∶1000–1∶5000 overnight at 4°C. After three washes with PBST, the blots were incubated with suitable horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) at a dilution of 1∶10,000 for 1 h. The blots were washed again and the proteins of interest detected by Amersham ECL Prime Western Blotting Detection Reagents (GE Healthcare), according to the manufacturer’s instructions, and then the chemiluminescence signal was visualized with Hyperfilm ECL X-ray film.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!